As we12,28,29 and others have published30–35, the SUM-190 cell line, derived from a patient with inflammatory breast cancer, has a HER2 gene amplification, and HER2 is overexpressed at the mRNA and protein level. The gene discussed is ERBB2; the disease is inflammatory breast carcinoma.